Very few studies using high-dose therapy and autologous bone marrow transplantation have a long (i.e., > 3 years) follow-up. We report here the 6-year update of a study employing high-dose sequential chemo-radiotherapy in 25 patients with poor-risk Hodgkin's disease.

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update / A. M. Gianni, S. Siena, M. Bregni, F. Lombardi, L. Gandola, M. Di Nicola, M. Magni, F. Peccatori, P. Valagussa, G. Bonadonna. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 4:10(1993 Dec), pp. 889-91-891.

High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update

A. M. Gianni;S. Siena;
1993

Abstract

Very few studies using high-dose therapy and autologous bone marrow transplantation have a long (i.e., > 3 years) follow-up. We report here the 6-year update of a study employing high-dose sequential chemo-radiotherapy in 25 patients with poor-risk Hodgkin's disease.
Prednisone; Combined Modality Therapy; Humans; Salvage Therapy; Vincristine; Vinblastine; Cyclophosphamide; Bleomycin; Epirubicin; Doxorubicin; Whole-Body Irradiation; Survival Rate; Cisplatin; Mechlorethamine; Adult; Treatment Outcome; Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Procarbazine; Actuarial Analysis; Hodgkin Disease; Bone Marrow Transplantation; Female
Settore MED/06 - Oncologia Medica
dic-1993
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/182109
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 66
  • ???jsp.display-item.citation.isi??? ND
social impact